innovation of this magnitude. His arrogance was infuriating. And yet
Safeway was still hesitant to walk away from the partnership. What if
the Theranos technology did turn out to be game-changing? It might
spend the next decade regretting passing up on it. The fear of missing
out was a powerful deterrent.
As for Burd, it was clear he hadn’t been ready to retire. Just three
months after leaving the supermarket chain, he founded a consulting
firm to advise companies on how to reduce their health-care costs. He
called it Burd Health. In his new role as a fellow health-startup
founder, he tried to get back in touch with Elizabeth. But she no longer
returned his calls.